CDC recommends Pfizer's RSV vaccine during pregnancy as protection for newborns
CBSN
An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory syncytial virus, or RSV, be given during pregnancy, providing an extra level of protection for newborns against the disease.
The panel recommended in an 11-1 vote that Pfizer's Abrysvo be given during weeks 32 to 36 of pregnancy. The recommendation was formally adopted by CDC Director Dr. Mandy Cohen.
Abrysvo was approved by the Food and Drug Administration for administration to pregnant people last month but needed the CDC's approval as well before it could be added to a list of "maternal vaccines" recommended before birth.

A jury has found Elon Musk liable for misleading investors by deliberately driving down Twitter's stock price in the tumultuous months leading up to his 2022 acquisition of the social media company for $44 billion. But it absolved him of some fraud allegations, finding that he did not "scheme" to mislead investors. In:












